16 employees
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.
2017
$100K
from 2 investors over 2 rounds
Endogenex raised undisclosed on November 30, 2018
Investors: -
Endogenex raised $100K on November 1, 2018
Investors: Southeast Minnesota Capital Fund LLC